Data / Drug companies / Tetrabenazine
Tetrabenazine: 12 companies and 24 products in the FDA NDC directory
Tetrabenazine is listed in the FDA National Drug Code Directory by 12 companies, with 24 products in commercial distribution. 20 of the products (83.3%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet; tablet, coated, and the newest product started marketing on September 1, 2025.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 12
- Products
- 24
- Generic (ANDA) products
- 20 (83.3%)
- Application numbers
- 9
- Routes
- Oral
- Brand names
- Xenazine
- openFDA record search
- api.fda.gov
Companies that list tetrabenazine
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Ajanta Pharma USA Inc. | 2 | tablet | Generic drugs (ANDA) | December 27, 2020 |
| Apotex Corp. | 2 | tablet | Generic drugs (ANDA) | June 18, 2020 |
| Bionpharma Inc. | 2 | tablet | Generic drugs (ANDA) | January 15, 2018 |
| Camber Pharmaceuticals, Inc. | 2 | tablet, coated | Generic drugs (ANDA) | August 17, 2015 |
| Dr. Reddy's Laboratories Inc. | 2 | tablet | Generic drugs (ANDA) | January 8, 2018 |
| Golden State Medical Supply, Inc. | 2 | tablet | Generic drugs (ANDA) | March 17, 2020 |
| Heritage Pharmaceuticals Inc. D/B/A Avet Pharmaceuticals Inc. | 2 | tablet | Generic drugs (ANDA) | September 1, 2025 |
| Lundbeck Pharmaceuticals LLC | 2 | tablet | New drug applications (NDA) | November 24, 2008 |
| Oceanside Pharmaceuticals | 2 | tablet | Authorized generics (NDA) | July 20, 2015 |
| Precision Dose, Inc. | 2 | tablet | Generic drugs (ANDA) | December 1, 2023 |
| Slate Run Pharmaceuticals, LLC | 2 | tablet | Generic drugs (ANDA) | March 2, 2020 |
| Sun Pharmaceutical Industries, Inc. | 2 | tablet | Generic drugs (ANDA) | August 17, 2015 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet | 22 | 91.7% |
| Tablet, coated | 2 | 8.3% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 20 | 83.3% |
| New drug applications (NDA) | 2 | 8.3% |
| Authorized generics (NDA) | 2 | 8.3% |
Pharmacologic classes
| Class | Products |
|---|---|
| Vesicular Monoamine Transporter 2 Inhibitor | 24 |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.